We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy.
- Authors
Rask, C; Lund, L; Lund, G; Heydenreich, B; Wurtzen, P; Bellinghausen, I; Saloga, J; Lund, K
- Abstract
Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a period of weeks. Commonly, in commercial products for SCIT, the specific allergen is formulated with an adjuvant, most often in the form of aluminium hydroxide (AlOH). It has been shown that allergen-specific IgG antibodies are induced as a result of successful SIT.
- Publication
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2012, Vol 42, Issue 9, p1356
- ISSN
1365-2222
- Publication type
Journal Article
- DOI
10.1111/j.1365-2222.2012.04026.x